Decima Health

Innovative, 100% Natural Skincare for all skin types
Visit Company Site

Decima Health has created scientifically developed, clinically proven, patented, natural and safe skincare products that are registered under the Atopis® brand. Founded in 2016 by Dr Iona Weir,  a scientist with extensive research experience in New Zealand and overseas in cell biology and biochemistry.

It has created a patented method of developing topical bioactive Over The Counter products utilising a novel process that uses all-natural ingredients. A revolutoinary process as, unlike conventional methods, the final product contains a far higher proportion of plant extracts as is far gentler on the extracts, so boosts activity.

The Atopis® Skincare range launched in 2017, holding global patents for clinically proven skincare that treat common issues like rosacea, acne, pigmentation, skin ageing and eczema. It has grown rapidly with strong international sales through the website and Amazon. In 2019 Atopis® began selling their Atopis® Eczema Therapy cream in the United States after achieving Over The Counter Pharmacy registration. In 2021, Decima will register other Atopis® creams targeting rosacea, acne and psoriasis for sale in the OTC market in the US, as well as expanding the Atopis® range. Atopis® will be releasing OTC creams for the Australian and New Zealand markets in the next 12 months.

Vortex Power Systems Limited are developing a proprietary system to convert any source of waste heat into a zero-carbon powerplant and generate electricity from the wasted energy. The system utilises wasted heat to create an atmospheric vortex and generate electricity from the high wind speeds produced. The team expect using this method could deliver an extra 5% power generation to an existing power station (geothermal, nuclear or coal-fired). This presents a multi-billion opportunity for the company. You can find further information below.

The company is led by a highly experienced team and board

  • Brent Ogilvie (Chairman) is also the managing director of Pacific Channel and ex-CEO of Engender Technologies
  • Perzaan Mehta (GM) is the ex-GM for Orbis Diagnostics. Perzaan’s last role was as Associate with Pacific Channel. He was instrumental in the DD effort into Vortex and ended up seeing so much potential he left Pacific Channel and took a full time role as GM. Perzaan is highly regarded by his previous colleagues.
  • Professor Richard Flay (Scientific lead) has been a professor of mechanical engineering for 27 years at the University of Auckland. He has a history of successful commercial ventures including developing the world’s first wind tunnel capable of producing twisted flow for testing yacht sails. This wind tunnel was used by Team New Zealand to win two Americas cups.

The offer:

  • Raising $1.3m

REGION – Auckland

INDUSTRY – Biotech

STAGE – Startup